Center for Public Health Genomics

The Center for Public Health Genomics (CPHG) addresses questions in biology, public health, and medicine by developing and applying state-of-the-art genetic, genomic, and computational approaches to complex human diseases.

Research in the CPHG is focused on translational genomics and personalized medicine — moving basic discoveries in genetics and genomics into clinical settings with the goal of improving the delivery of health care and disease prevention.

Our research projects range from gene discovery to pharmacogenomics to mouse models of human disease. Labs in the CPHG offer graduate research and training opportunities through the UVA School of Medicine, Biomedical Engineering,  and the College of Arts and Sciences graduate programs.


The Future

Public health genomics is a multi-disciplinary field that focuses on the effective and responsible translation of genetic information and technology for the benefit of population health. A major focus of our work translates genomic discoveries to appropriate population level assessments, policies and disease prevention programs.

Learn More

UVA CPHG Scientist working in lab

Center for Public Health Genomics Education

Graduate students identify CPHG mentors and conduct research in CPHG faculty laboratories. This research leads to degrees in disciplines that are typically multidisciplinary.

Read More

Speaker giving seminar at CPHG, UVA

UVA Seminar Series

The Center for Public Health Genomics operates three seminar series: the Emerging Scholars in Genome Sciences Symposium in the Fall, the weekly Genome Sciences Seminar Series (GS3) in both Fall and Spring semesters, and the semi-monthly CPHG Research in Progress (CPHG-RIP) in both Fall and Spring semesters.

Current Schedule

Review of Human Genome IDs Stroke Risk Genes

Researchers seeking to better understand how our genes contribute to stroke risk have completed what is believed to be the largest and most comprehensive review of the human genome to identify genes that predispose people to ischemic stroke, the cause of approximately 85 percent of all strokes.

Learn More

News All News »

Noah Perry & Mete Civelek Discover Critical Biological Processes that Contribute to Coronary Artery Disease

CORONARY ARTERY DISEASE DISCOVERY OFFERS ANSWERS ABOUT NATION’S NO. 1 KILLER UVA researchers say they have found a biological process that contributes to the disease and may be a target…

Y. Michael Shim, MD, and CPHG’s Ani Manichaikul, PhD, Awarded $3 Million Grant

Y. Michael Shim, MD, a professor of medicine in the Division of Pulmonary and Critical Care Medicine and Ani Manichaikul, PhD, an associate professor in the Center for Public Health…

Keith Keene Leads New Center for Health Equity and Precision Public Health (CHEPPH)

The new CHEPPH is led by Keith Keene, PhD, a geneticist and former postdoc at UVA’s Center for Public Health Genomics who has returned to UVA from East Carolina University.…

Events All Events »

Genome Sciences Seminar

Speaker: Alice Berger, PhD, Fred Hutchinson Institute Understanding the Functional Cancer Genome to Enable Precision Medicine The Genome Sciences Seminar Series (GS3) is held on Wednesdays from 1:00 – 2:00pm…

Genome Sciences Seminar

Speaker: Diana Cousminer, PhD, GlaxoSmithKline Title TBD The Genome Sciences Seminar Series (GS3) is held on Wednesdays from 1:00 – 2:00pm Eastern from September 27, 2023 - December 6, 2023.

Research In Progress (RIP)

John Platig   The Research in Progress takes place on the 2nd & 4th Mondays of each month from September 25, 2023 - April 22, 2024.

Genome Sciences Seminar

Speaker: Heidi Rehm, PhD, FACMG, Broad Institute & Massachusetts General Hospital Advancing Genomic Medicine through Global Collaboration The Genome Sciences Seminar Series (GS3) is held on Wednesdays from 1:00 –…

Research In Progress (RIP)

Michael Love, Associate Professor, Departments of Biostatistics & Genetics, University of North Carolina   The Research in Progress takes place on the 2nd & 4th Mondays of each month from…

Recent Publications

Multi-Ancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.